We’re finding answers.

Dr Mohit Misra brings 20 years of broad healthcare experience to Mango Sciences with a background as a surgeon, trained health economist, top tier strategy consultant, and investor with experience building teams in early stage companies.

Until recently, Mohit was Head of Digital Health at TPG’s Evercare Health Fund. Prior to this, he was Chief Medical Officer and VP of Health Systems of the Harvard big data spin out Aetion, leading a commercial team in working across Europe and the US. He has also worked extensively in life sciences strategy consulting in Europe and the US at London-based Booz&Co. Mohit has policy experience at the UK Dept. of Health and the World Health Organization, and sat on the prestigious UK NICE Health Technology Assessment Committee who assess all new drugs for the NHS for 6 years.

He obtained his Bachelors in Immunology and MD from King’s College London and his Masters in Health Economics from the London School of Economics.

Vamsi Chandra Kasivajjala brings over 20 years of health tech experience to Mango Sciences as a serial entrepreneur with three successful exits.

He co-founded Enlightiks and grew it to be the world’s 8th largest Provider AI & Analytics platform with over 28 million patient lives. Previously, he served as an advisor to Govt of Karnataka and Head of Operations for Philips Informatics Division in India. Vamsi created Asia’s third largest health tech product division at SRIT and built and implemented EMR, medical imaging, CDSS products, and more at hundreds of hospitals across 40 countries, finally successfully sold the division to Religare Technologies (Healthfore) and continuing to lead as CTO. Prior to that, Vamsi implemented tele-medicine technologies in 11 countries in Eastern and Sub Saharan Africa, and before that he built India’s largest Beowulf Cluster Computer.

Vamsi studied Computer Science at IIT Kharagpur and is currently on the Board of Foundation AI and HIMSS India chapter. He was also mentioned by the current Microsoft CEO Satya Nadella in his book ‘Hit Refresh’ for his Atrial Fibrillation model and has published 8 papers in Healthcare AI.

Gavin comes with a proven track record and he is an accomplished leader responsible for developing and managing the RWE Analytics franchise, supporting all analytic functions serving the life science industry. Gavin has worked extensively in outcomes research, partnering with clients to develop research ideas that crystalize the value story of their products. Gavin has got 15+ years of data science experience in Life Sciences & customer-facing engagements, leading the team from data selection and study design through to communication of final recommendations.

Gavin’s current interest & focus area is innovation in the application of AI/machine learning to real-world data. Gavin has completed his Masters from Harvard T H Chan School of Public Health, Boston, MA, and Bachelors from Massachusetts Institute of Technology (MIT), Cambridge, MA.

Todd Gorsuch is the Chief Commercial Officer for Mango Sciences. He has two decades of experience driving growth and profitability for early stage companies.

Prior to Mango, he was VP, Head of Commercialization for Harvard big data spin out Aetion where he initially led the Life Sciences global commercial team and then expanded his responsibilities to include global commercialization across the Life Sciences, Health Plan and Provider markets. He was a member of the senior leadership team responsible for raising over $70 million in funding over two rounds. Todd’s experience in the real world evidence market began at Premier, Inc. where he served as the senior sales leader responsible for launching Premier’s life sciences business. His work experience also includes pharmaceutical sales and marketing roles at Merck & Co.

Todd started his career as an officer in the United States Air Force. He obtained his Bachelors of Science degree from the United States Air Force Academy and his MBA from The Citadel’s College of Graduate Studies. When Todd is not working, he can be found unplugged and outdoors enjoying Maine’s four unique and beautiful seasons.

Kevin Kozel serves as Vice President, Head of Life Sciences, and comes to Mango with nearly
two decades of healthcare experience.
Prior to Mango Sciences, Kevin was Vice President of Strategic Accounts for Harvard big data
spin out Aetion. As an early member of the Aetion team, Kevin was instrumental in assuring
year over year revenue growth while also helping expand the team of 20 employees to more
than 150 at the time of his departure to Mango Sciences. Additional experience includes
various business units and responsibilities within Premier Inc., regional sales for Pfizer
pharmaceuticals, and corporate business strategy for healthcare startup Epocrates.
With an expansive career throughout the healthcare ecosystem, Kevin brings a wealth of insight
and expertise to Mango Sciences. From more than a decade of Real World Data and Analytics
experience, coupled with time spent working within global pharmaceutical companies and
aiding hospitals in process improvement and benchmarking, Kevin has a unique background
which enables him to strategically align our clients goals with initiatives to help assure their
success.
Kevin graduated Magna Cum Laude with a Bachelor of Arts from the University of Scranton and
continues taking part in executive level trainings and classes. Currently, Kevin resides outside
of Charlotte, NC with his wife and 3 children.

Ramnath is the Head of Strategic Finance for Mango Sciences. He has spent close to 16 years in the Indian financial sector with pedigreed firms in a career spanning equity research (focused on BFSI sector), portfolio management, and corporate strategy. His assignments included creating new business cases, developing capable teams, and driving execution across these firms. He is now leading the engagement program with our financial sector partners.

He is a B.Tech from the Indian Institute of Technology, Kharagpur, and a management graduate from the Indian Institute of Management, Calcutta.